Allarity Therapeutics Inc (ALLR): Yes I did that’s why I sold @$13

Reply Private New

Replies (1) Next 10 Prev Next

Send PM Follow Ignore

Followers	171
Posts	22601
Boards Moderated	0
Alias Born	11/01/2012

INFINITI

Re: ghosttrader13 post# 229

Wednesday, 07/05/2023 4:28:37 PM

Wednesday, July 05, 2023 4:28:37 PM

Yes I did that’s why I sold @$13

Keep Last Read

Replies (1) Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent ALLR News

Form 8-K - Current report • Edgar (US Regulatory) • 10/23/2024 12:01:13 PM
Allarity Therapeutics to be Granted European Patent for DRP® Companion Diagnostic for Stenoparib • GlobeNewswire Inc. • 10/22/2024 12:00:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/11/2024 12:00:29 PM
Allarity Therapeutics Regains Compliance with NASDAQ Minimum Bid Price Requirement • GlobeNewswire Inc. • 10/10/2024 12:00:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/04/2024 12:00:34 PM
Allarity Therapeutics Strengthens Leadership with Key Appointments to Accelerate Stenoparib PARP Inhibitor Program • GlobeNewswire Inc. • 10/03/2024 12:00:00 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/01/2024 09:34:12 PM
Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 10/01/2024 09:32:57 PM
Form 8-K - Current report • Edgar (US Regulatory) • 09/17/2024 12:00:32 PM
Allarity Therapeutics Announces Two Patients Now Exceeding One Year of Treatment with Stenoparib in Advanced Ovarian Cancer Trial • GlobeNewswire Inc. • 09/16/2024 12:00:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 09/13/2024 12:53:18 PM
Allarity Therapeutics Announces New CFO and Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 09/13/2024 12:45:00 PM
Allarity Therapeutics Takes Decisive Step Toward Regaining Nasdaq Compliance with Nasdaq Listing Rule 5550(a)(2) • GlobeNewswire Inc. • 09/11/2024 12:00:00 PM
Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 09/10/2024 01:15:59 PM
Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 09/09/2024 08:05:26 PM
Form 8-K - Current report • Edgar (US Regulatory) • 09/09/2024 01:00:09 PM
Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 08/30/2024 08:05:53 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/21/2024 08:55:50 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/05/2024 09:24:15 PM
Allarity Therapeutics Announces Postponement of Annual Stockholders Meeting • GlobeNewswire Inc. • 07/26/2024 01:00:00 PM
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 07/26/2024 10:04:13 AM
Allarity Encourages Shareholders to Vote FOR the Reverse Stock Split and Decrease in Authorized Shares • GlobeNewswire Inc. • 07/24/2024 10:00:00 AM
Form 8-K - Current report • Edgar (US Regulatory) • 07/23/2024 08:05:17 PM

More ALLR News

InvestorsHub NewsWire

CBD Life Sciences Inc. (CBDL) Launches High-Demand Mushroom Gummy Line for Targeted Wellness Needs, Tapping into a Booming $20 Billion Market • CBDL • Oct 31, 2024 8:00 AM

Nerds On Site Announces Q1 Growth and New Initiatives for the Remainder of 2024 • NOSUF • Oct 31, 2024 7:01 AM

Innovation Beverage Group Receives Largest Shipment of its Top-Selling Bitters to Date in the U.S.-Ready to Meet Growing Demand from Expanding Distribution Network • IBG • Oct 30, 2024 12:22 PM

Element79 Gold Corp to Update Investors on the Emerging Growth Conference on October 31, 2024 • ELMGF • Oct 30, 2024 9:08 AM

CBD Life Sciences Inc. (CBDL) Announces Grand View Research Report Findings on High - Growth CBD Equine Market, Aiming to Drive Unprecedented Shareholder Value • CBDL • Oct 29, 2024 10:19 AM

Integrated Ventures Announces Partnership And Lease Agreement with Driptide Wellness - Leading Health and Wellness Provider. • INTV • Oct 29, 2024 8:45 AM

Start posting your company's news

Only $200 per official company press release!

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover